Promotion of Arterial Stiffness by Childhood Cancer and Its Characteristics in Adult Long-Term Survivors

Natalie Arnold, Hiltrud Merzenich, Arthur Wingerter, Andreas Schulz, Astrid Schneider, Jürgen H Prochaska, Sebastian Göbel, Marie A Neu, Nicole Henninger, Marina Panova-Noeva, Susan Eckerle, Claudia Spix, Irene Schmidtmann, Karl J Lackner, Manfred E Beutel, Norbert Pfeiffer, Thomas Münzel, Jörg Faber, Philipp S Wild, Natalie Arnold, Hiltrud Merzenich, Arthur Wingerter, Andreas Schulz, Astrid Schneider, Jürgen H Prochaska, Sebastian Göbel, Marie A Neu, Nicole Henninger, Marina Panova-Noeva, Susan Eckerle, Claudia Spix, Irene Schmidtmann, Karl J Lackner, Manfred E Beutel, Norbert Pfeiffer, Thomas Münzel, Jörg Faber, Philipp S Wild

Abstract

Background Vascular alterations induced by antineoplastic treatment might be considered as a possible underlying mechanism of increased cardiovascular sequelae in childhood cancer survivors (CCSs). We aimed to evaluate arterial stiffness among long-term CCSs and to compare the data against a population-based sample. Methods and Results Arterial stiffness was assessed by digital photoplethysmography (stiffness index; m/s) among 1002 participants of the CVSS (Cardiac and Vascular Late Sequelae in Long-Term Survivors of Childhood Cancer) study, diagnosed with neoplasia (1980-1990) before an age of 15 years. A population-based sample from the GHS (Gutenberg Health Study) (n=5252) was investigated for comparison. All subjects underwent a comprehensive, standardized clinical examination in the same study center. CCSs had higher stiffness index (β=0.66 m/s; 95% CI, 0.51-0.80 m/s) in multivariable linear regression analysis after adjustment for cardiovascular risk factors compared with the population sample of comparable age range. Stiffer vessels were found among CCSs also in absence of arterial hypertension (β=0.66; 95% CI, 0.50-0.81) or history of chemotherapy/radiotherapy (β=0.56; 95% CI, 0.16-0.96) in fully adjusted models. Moreover, stiffness index differed by tumor entity, with highest values in bone and renal tumors. Almost 5.2-fold higher prevalence of stiffness index values exceeding age-specific, population-based reference limits was observed among CCSs compared with GHS participants. Conclusions This is the first study demonstrating increased arterial stiffness among long-term CCSs. The data suggest that vascular compliance might differ in survivors of childhood cancer from the established development concept for arterial stiffness in the population; cancer growth and antineoplastic treatment might be relevant determinants of the pathobiological features. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02181049.

Keywords: arterial stiffness; childhood cancer survivors; general population.

Conflict of interest statement

Drs Wild, Prochaska, and Panova‐Noeva are funded by the Federal Ministry of Education and Research (Federal Ministry of Education and Research 01EO1503). Drs Wild and Münzel are principal investigators, and Drs Arnold, Prochaska, Panova‐Noeva, Lackner, and Göbel are scientists of the German Centre for Cardiovascular Research. The remaining authors have no disclosures to report.

Figures

Figure 1. Age‐related increase of stiffness index…
Figure 1. Age‐related increase of stiffness index in childhood cancer survivors and in the population.
Conditional density plots were generated and nonparametric bootstrap samples (n=1000) were run to estimate 95% CIs. Data were calculated on the basis of a CVSS (Cardiac and Vascular Late Sequelae in Long‐Term Survivors of Childhood Cancer) study sample, aged 30 to 45 years, and a GHS (Gutenberg Health Study) sample, aged 35 to 50 years.
Figure 2. Age‐ and sex‐adjusted arterial stiffness,…
Figure 2. Age‐ and sex‐adjusted arterial stiffness, according to tumor entity.
Data presented as age‐ and sex‐adjusted means for stiffness index, measured by digital photoplethysmography, with their 95% CIs. CNS indicates central nervous system.
Figure 3. Difference in stiffness index in…
Figure 3. Difference in stiffness index in childhood cancer survivors compared with a population sample, according to tumor entity.
Results from multivariable linear regression analysis with stiffness index as dependent variable and adjustment for age, sex, diabetes mellitus, arterial hypertension, smoking, obesity, dyslipidemia, and family history of myocardial infarction/stroke. Data presented as β estimates with their 95% CIs. CNS indicates central nervous system; ICCC3, International Classification of Childhood Cancer; and ref., reference.

References

    1. Armstrong GT, Chen Y, Yasui Y, Leisenring W, Gibson TM, Mertens AC, Stovall M, Oeffinger KC, Bhatia S, Krull KR, et al. Reduction in late mortality among 5‐year survivors of childhood cancer. N Engl J Med. 2016;374:833–842.DOI: 10.1056/NEJMoa1510795
    1. Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson MM, Kremer LC, Landy DC, Miller TL, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiolo . Long‐term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128:1927–1995.DOI: 10.1161/CIR.0b013e3182a88099
    1. Lipshultz SE, Sambatakos P, Maguire M, Karnik R, Ross SW, Franco VI, Miller TL. Cardiotoxicity and cardioprotection in childhood cancer. Acta Haematol. 2014;132:391–399.DOI: 10.1159/000360238
    1. Svilaas T, Lefrandt JD, Gietema JA, Kamphuisen PW. Long‐term arterial complications of chemotherapy in patients with cancer. Thromb Res. 2016;140:S109–S118.DOI: 10.1016/S0049-3848(16)30109-8
    1. Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Vascular toxicities of cancer therapies: the old and the new–an evolving avenue. Circulation. 2016;133:1272–1289.DOI: 10.1161/CIRCULATIONAHA.115.018347
    1. Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Münzel T, Lackner KJ, Beutel ME, Blettner M, Rathmann W, et al. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS‐study. Eur Heart J. 2018;39:1555–1562.DOI: 10.1093/eurheartj/ehy026
    1. Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698–722.DOI: 10.1161/HYP.0000000000000033
    1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all‐cause mortality with arterial stiffness: a systematic review and meta‐analysis. J Am Coll Cardiol. 2010;55:1318–1327.DOI: 10.1016/j.jacc.2009.10.061
    1. Drafts BC, Twomley KM, D'Agostino R, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, et al. Low to moderate dose anthracycline‐based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6:877–885.DOI: 10.1016/j.jcmg.2012.11.017
    1. Mozos I, Borzak G, Caraba A, Mihaescu R. Arterial stiffness in hematologic malignancies. Onco Targets Ther. 2017;10:1381–1388.
    1. Jenei Z, Bárdi E, Magyar MT, Horváth A, Paragh G, Kiss C. Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer. Pathol Oncol Res. 2013;19:375–383.DOI: 10.1007/s12253-012-9589-6
    1. Krystal JI, Reppucci M, Mayr T, Fish JD, Sethna C. Arterial stiffness in childhood cancer survivors. Pediatr Blood Cancer. 2015;62:1832–1837.DOI: 10.1002/pbc.25547
    1. Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry—annual report 2017 (1980–2015). In: Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
    1. Arnold N, Gori T, Schnabel RB, Schulz A, Prochaska JH, Zeller T, Binder H, Pfeiffer N, Beutel M, Espinola‐Klein C, et al. Relation between arterial stiffness and markers of inflammation and hemostasis—data from the population‐based Gutenberg Health Study. Sci Rep. 2017;7:6346. DOI: 10.1038/s41598-017-06175-2
    1. Dawber TR, Thomas HE Jr, McNamara PM. Characteristics of the dicrotic notch of the arterial pulse wave in coronary heart disease. Angiology. 1973;24:244–255.DOI: 10.1177/000331977302400407
    1. Chow AY, Chin C, Dahl G, Rosenthal DN. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006;24:925–928.DOI: 10.1200/JCO.2005.03.5956
    1. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol. 2007;80:S23–S31.DOI: 10.1259/bjr/18237646
    1. Halle M, Gabrielsen A, Paulsson‐Berne G, Gahm C, Agardh HE, Farnebo F, Tornvall P. Sustained inflammation due to nuclear factor‐kappa B activation in irradiated human arteries. J Am Coll Cardiol. 2010;55:1227–1236.DOI: 10.1016/j.jacc.2009.10.047
    1. Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97:149–161.DOI: 10.1016/j.radonc.2010.09.002
    1. Lipshultz SE, Landy DC, Lopez‐Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, French CA, Rovitelli AM, Proukou C, Adams MJ, et al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol. 2012;30:1050–1057.DOI: 10.1200/JCO.2010.33.7907
    1. Panova‐Noeva M, Schulz A, Arnold N, Hermanns MI, Prochaska JH, Laubert‐Reh D, Spronk HM, Blettner M, Beutel M, Pfeiffer N, et al. Coagulation and inflammation in long‐term cancer survivors: results from the adult population. J Thromb Haemost. 2018;16:699–708.DOI: 10.1111/jth.13975
    1. Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, Whitton J, Robison LL, Gurney JG. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2382–2389.DOI: 10.1200/JCO.2008.21.1482
    1. Ness KK, Leisenring WM, Huang S, Hudson MM, Gurney JG, Whelan K, Hobbie WL, Armstrong GT, Robison LL, Oeffinger KC. Predictors of inactive lifestyle among adult survivors of childhood cancer. Cancer. 2009;115:1984–1994.DOI: 10.1002/cncr.24209
    1. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007;110:2313–2320.DOI: 10.1002/cncr.23050
    1. Sobczuk P, Szczylik C, Porta C, Czarnecka AM. Renin angiotensin system deregulation as renal cancer risk factor. Oncol Lett. 2017;14:5059–5068.
    1. Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL‐BFM 86, 90, and 95. Klin Padiatr. 2005;217:310–320. DOI: 10.1055/s-2005-872515
    1. Hossain MJ, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol. 2014;2014:865979. DOI: 10.1155/2014/865979

Source: PubMed

3
購読する